| Authors: |
Chuntova P; Department of Neurological Surgery, UCSF, San Francisco, California., Chow F; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California., Watchmaker PB; Department of Neurological Surgery, UCSF, San Francisco, California., Galvez M; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, Los Angeles, California., Heimberger AB; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Diaz A; Department of Neurological Surgery, UCSF, San Francisco, California., DePinho RA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Li MO; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Wherry EJ; Department of Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Mitchell D; Department of Neurosurgery, University of Florida College of Medicine, Gainesville, Florida., Terabe M; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Wainwright DA; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Berzofsky JA; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Herold-Mende C; Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany., Heath JR; Institute for Systems Biology, Seattle, Washington., Lim M; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland., Margolin KA; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts., Kasahara N; Department of Neurological Surgery, UCSF, San Francisco, California., Ellingson BM; Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California., Brown CE; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, California., Chen Y; Department of Microbiology, Immunology & Molecular Genetics, UCLA, Los Angeles, California., Fecci PE; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina., Reardon DA; Department of Medicine/Medical Oncology, Harvard Medical School, Boston, Massachusetts., Dunn GP; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri., Liau LM; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California., Costello JF; Department of Neurological Surgery, UCSF, San Francisco, California., Wick W; Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany., Cloughesy T; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California., Timmer WC; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Prins RM; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, Los Angeles, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California., Platten M; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany.; DKTK CCU Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Okada H; Department of Neurological Surgery, UCSF, San Francisco, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California. |
